270 related articles for article (PubMed ID: 29986353)
1. The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.
Lazarus JV; Safreed-Harmon K; Thursz MR; Dillon JF; El-Sayed MH; Elsharkawy AM; Hatzakis A; Jadoul M; Prestileo T; Razavi H; Rockstroh JK; Wiktor SZ; Colombo M
Semin Liver Dis; 2018 Aug; 38(3):181-192. PubMed ID: 29986353
[TBL] [Abstract][Full Text] [Related]
2. Eliminating viral hepatitis C in Belgium: the micro-elimination approach.
Busschots D; Toghanian S; Bielen R; Salomonsson S; Koc ÖM; Hendrickx G; Jadoul M; Nevens F; Sokal E; Brixko C; Peerlinck K; Apers L; Robaeys G; Lazarus JV
BMC Infect Dis; 2020 Feb; 20(1):181. PubMed ID: 32106819
[TBL] [Abstract][Full Text] [Related]
3. How would China achieve WHO's target of eliminating HCV by 2030?
Li M; Zhuang H; Wei L
Expert Rev Anti Infect Ther; 2019 Oct; 17(10):763-773. PubMed ID: 31578079
[No Abstract] [Full Text] [Related]
4. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
[TBL] [Abstract][Full Text] [Related]
5. Securing sustainable funding for viral hepatitis elimination plans.
Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
[TBL] [Abstract][Full Text] [Related]
6. Elimination of hepatitis C in Europe: can WHO targets be achieved?
Matičič M; Lombardi A; Mondelli MU; Colombo M;
Clin Microbiol Infect; 2020 Jul; 26(7):818-823. PubMed ID: 31978546
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C: Is eradication possible?
Lombardi A; Mondelli MU;
Liver Int; 2019 Mar; 39(3):416-426. PubMed ID: 30472772
[TBL] [Abstract][Full Text] [Related]
8. A micro-elimination approach to addressing hepatitis C in Turkey.
Idilman R; Razavi H; Robbins-Scott S; Akarca US; Örmeci N; Kaymakoglu S; Aygen B; Tozun N; Güner R; Bodur H; Lazarus JV
BMC Health Serv Res; 2020 Mar; 20(1):249. PubMed ID: 32209103
[TBL] [Abstract][Full Text] [Related]
9. Measuring hepatitis C virus elimination as a public health threat: Beyond global targets.
van Santen DK; Sacks-Davis R; Doyle JS; Scott N; Prins M; Hellard M
J Viral Hepat; 2020 Aug; 27(8):770-773. PubMed ID: 32187431
[TBL] [Abstract][Full Text] [Related]
10. Innovations in Hepatitis C Screening and Treatment.
Patel AA; Bui A; Prohl E; Bhattacharya D; Wang S; Branch AD; Perumalswami PV
Hepatol Commun; 2021 Mar; 5(3):371-386. PubMed ID: 33681673
[TBL] [Abstract][Full Text] [Related]
11. The global elimination of hepatitis C?
Sonderup MW
S Afr Med J; 2018 Aug; 108(8b):31-34. PubMed ID: 30182910
[TBL] [Abstract][Full Text] [Related]
12. Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic.
Bajis S; Applegate TL; Grebely J; Matthews GV; Dore GJ
J Infect Dis; 2020 Nov; 222(Suppl 9):S758-S772. PubMed ID: 33245354
[TBL] [Abstract][Full Text] [Related]
13. Eliminating hepatitis C.
Burki T
Lancet Infect Dis; 2019 Mar; 19(3):246-247. PubMed ID: 30833063
[No Abstract] [Full Text] [Related]
14. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
European Union HCV Collaborators
Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):391-400. PubMed ID: 33857445
[TBL] [Abstract][Full Text] [Related]
16. Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements.
Kondili LA; Craxì A; Aghemo A
Liver Int; 2021 Apr; 41(4):649-655. PubMed ID: 33486885
[TBL] [Abstract][Full Text] [Related]
17. The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges.
Behzadifar M; Azari S; Gorji HA; Martini M; Bragazzi NL
J Prev Med Hyg; 2020 Mar; 61(1):E109-E118. PubMed ID: 32490276
[TBL] [Abstract][Full Text] [Related]
18. Global hepatitis C elimination: an investment framework.
Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
[TBL] [Abstract][Full Text] [Related]
19. Localized US Efforts to Eliminate Hepatitis C.
Gaudino A; Gay B; Garmon C; Selick M; Vreeland R; Burk K; Huriaux E; Facente SN; Luetkemeyer A; Waters P; Graham CS
Infect Dis Clin North Am; 2018 Jun; 32(2):293-311. PubMed ID: 29778257
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C treatment as prevention: evidence, feasibility, and challenges.
Hajarizadeh B; Grebely J; Martinello M; Matthews GV; Lloyd AR; Dore GJ
Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):317-327. PubMed ID: 28404202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
